Please ensure Javascript is enabled for purposes of website accessibility
Home / Today's Top Stories / B&L links with LASIK patent holder

B&L links with LASIK patent holder

Bausch & Lomb Inc. is partnering with the inventor and key patent holder of the LASIK method of eye surgery to develop new technology. The partnership was one of two moves made announced over the weekend by the eye-care company. On Friday, Bausch & Lomb filed a complaint against competitor Alcon Pharmaceuticals Inc. for false and misleading advertising and promotional claims.
The new surgical procedure, PAI-LASIK, has the potential to extend the range of nearsightedness correctable by Laser in Situ Keratomileusis, and also make the procedure reversible, if necessary.
Bausch & Lomb has obtained exclusive development and marketing rights to this technology-photoablative inlay-from its inventor, Gholam Peyman M.D. of Tulane University of Louisiana’s Medical School in New Orleans, and patent holder North Carolina-based Stromax Technologies LLC.
The technology consists of a corneal inlay is designed to shape the human cornea during laser vision correction surgery.
“First, such a new procedure would preserve the patient’s corneal tissue, thereby reducing the risk of creating a cornea that’s too thin and, therefore prone to weakening, leading to unstable refractive results,” Peyman said.
Bausch & Lomb will work with Peyman and Stromax throughout the product development. The team’s first assignment is to identify corneal inlay material that will produce optimal results, after which clinical studies will begin.
Bausch & Lomb’s Technolas 217 excimer laser will help create the correction.
On the lens care solution front, the company’s complaint against Alcon seeks immediate withdrawal of promotional materials for Alcon’s Opti-Free Express Multi-Purpose disinfecting solution.
Bausch & Lomb claims that Alcon’s marketing efforts contain false comparisons to competitive products, including its own offering, ReNu MultiPlus solution.
“While hyping the fact that their new product claim allows some patients to clean and disinfect contact lenses without rubbing them, Alcon underplays or fails to mention additional cleaning requirements,” said James Milton, president of North American Vision Care at Bausch & Lomb.
The Rochester-based eye-care company further suggests that there is no scientific data to support Alcon’s claim.
Alcon’s Opti-Free received FDA clearance to add a “no-rub” claim to product packaging this September.
Bausch & Lomb (NYSE:BOL) launched ReNu Multi-Plus in 1997 as the first all-in-one solution to eliminate the need for a separate enzymatic or daily cleaner for many contact lens wearers.

B&L links with LASIK patent holder

Bausch & Lomb Inc. is partnering with the inventor and key patent holder of the LASIK method of eye surgery to develop new technology. The partnership was one of two moves made announced over the weekend by the eye-care company. On Friday, Bausch & Lomb filed a complaint against competitor Alcon Pharmaceuticals Inc. for false and misleading advertising and promotional claims.

x

Check Also

Best Places to Work For DEI honorees announced (access required)

The Rochester Business Journal has announced the honorees for the inaugural Best Places to Work For DEI awards. This regional ...

City will allot $14.5M in ARPA funding for workforce development (access required)

Nine human-services organizations will use $14.5 million in federal funding allotted to the city of Rochester to engage more than ...

New state mandate for non-public schools provides clearer language, guidance (access required)

After years of conversation, public comments, and often contentious debate, the New York State Board of Regents unanimously voted on ...

REDCOM founders to receive philanthropy award from RIT

REDCOM founders to receive philanthropy award from RIT   (access required)

Saunders College of Business at Rochester Institute of Technology will honor the Gueldenpfennig family for their dedication as alumni and longtime RIT supporters with ...